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Attention plays a crucial role in functional neurological disorders. Attention to the
symptoms leads to their exacerbation and distraction to their improvement or even
transitory disappearance.
Objective: The aim was to test if the alerting, orienting and particularly the executive
aspect of attention are affected in functional movement disorders.
Methods: Thirty patients with a functional movement disorder, 30 patients with an
organicmovement disorder and 30 healthy controls performed the attention network test.
Results: The alerting and orienting effects were normal, but executive control of attention
under conflict was abnormal in patients with functional movement disorders, compared
to patients with an organic movement disorder and healthy controls.
Conclusion: Executive dysfunction seems to be an important secondary feature
of functional movement disorders, due to the overutilization of attentional resources
for explicit movement control. Furthermore, it provides an explanation for seemingly
unrelated symptoms commonly associated with functional movement disorders, such
as concentration difficulties and fatigue.
Keywords: attention, attention network test, functional neurological disorder, functional movement disorders,
conversion disorder, movement disorders, executive, cognitive
INTRODUCTION
Functional movement disorders (FMD) manifest as movement disorders that are genuine, but
often illogical or incongruent. As such they often fluctuate, and non-physiological maneuvers may
improve or worsen them. They cannot be explained by any structural, biochemical or genetic
abnormality. Functional disorders are known by many different names: in psychiatry they are
known as conversion disorders. The idea being that psychological trauma is converted into physical
symptoms. The terms psychogenic or psychosomatic share the same rationale. Other names are
medically unexplained or non-organic disorders.
Attention can be viewed as a set of processes that allow us to ignore irrelevant information and
use the brain’s limited processing capacity for the information that is most important in a given
situation (1).
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Attention plays a pivotal role in functional movement
disorders. This is apparent in terms of symptoms, signs,
and neurobiology: attention to the symptoms leads to their
exacerbation and distraction to their improvement or even
transitory disappearance (2). Indeed, distractibility is one of
the main diagnostic features of functional movement disorders
(3, 4): functional tremor, for example, diminishes or disappears
transitorily when the patient’s attention is distracted away from it.
Hoover’s sign in functional leg weakness is the demonstration of
normal strength when themovement is performed automatically,
without any attention, as opposed to weakness or paralysis when
the person attempts to move the affected limb voluntarily. At
a pathophysiological level, abnormally focused attention can be
implicated in symptom generation (5). In a Bayesian framework,
attention to the symptom, coupled with a strong prior belief in
its presence, can override the actual sensory input and shift the
overall perception and/or execution to conform to the symptom
(6, 7).
A crucial question is therefore whether attention is abnormal
in FMD. Standard measures of attention have generally been
found to be normal in functional movement disorders and
even in functional neurological disorders in general, with the
exception of non-epileptic attack disorder (8, 9). Yet, in the case
of functional movement disorders, relatively few studies have
been performed to date.
Recent models analyze attention into three separable
components, dependent on different brain networks: alerting,
orienting and executive. The alerting network, as the name
implies, leads to alertness and vigilance. The orienting network
allows to focus either on a location in space or a modality, i.e.
a specific feature. Finally, the executive network is involved in
“top-down” control, in focal attention, and conflict resolution
(withholding a response in favor of a less obvious response)
(10, 11). The attention network test (ANT), is a behavioral
test that allows to differentiate the alerting, orienting and
executive networks’ efficiencies in a single task (12). The
ANT involves responding to a left or right target arrow by
pressing a left or right keyboard key as quickly as possible.
The target arrow is surrounded by two flankers on either
side: lines (neutral flankers), or arrows pointing in the same
direction (congruent flankers) or the opposite direction with
regards to the target arrow (incongruent flankers). Prior
to the presentation of the arrow there is either no cue, a
temporally informative cue, or a temporally and spatially
informative cue. The alerting effect is measured by the reaction
time (RT) difference between the temporally informative
cue condition and the no cue condition. The orienting
effect is the RT difference between the both spatially and
temporally informative cue condition and the solely temporally
informative cue condition. The executive or conflict effect
is the difference in RT to the incongruent vs. the congruent
flanker arrows.
A previous ANT study in patients with chronic fatigue
syndrome with depression and without depression and a healthy
control group, showed normal alerting and orienting effects
and a non-significant trend to abnormalities in the executive
component in both patient groups (13).
In a modified version of the ANT, the ANT-I (14), the alerting
cue is a tone presented before the visual cue, the cue validity is
only 50%, i.e., non-informative and there are only two flanker
types (congruent and incongruent arrows). A previous study
using ANT-I with fibromyalgia patients showed an impairment
of both the alerting and the executive components of attention
(15). Pain, the main feature of fibromyalgia, is well-known to
influence attention.
Given the clinically evident central role of attention in
functional movement disorders, we set out to systematically
evaluate the different attentional networks in people with
functional movement disorders by means of the ANT. So as
to differentiate the impact of a functional movement disorder
from a movement disorder per se, people with FMD were
compared not only to healthy controls, but also to people with
an organic movement disorder. Other than through the influence
of medication or fatigue, the alerting effect was not expected to
be affected in functional movement disorders. Although a strong
focus on the symptom might lead to an inability to shift the
attentional focus away from it, a sudden exogenous stimulus
in space automatically attracts attention (so called “bottom-up”
attention). The orienting aspect of attention in the attention
network test was therefore expected to be normal. Executive
function is the most cognitively demanding and non-automatic
aspect of attention. Out of the three components it is the most
likely to be affected in functional movement disorders.
METHODS
Participants
Patients with functional and organic movement disorders were
primarily recruited from the clinical practice of expert movement
disorder and functional movement disorder specialists (KB and
ME) and the diagnosis was confirmed on the day of the study by
a further neurologist (ACH). The characteristics of the 30 patients
with a functional movement disorder (FMD), the 30 patients with
an organic movement disorder (organic controls OC) and the 30
healthy controls (HC) are summarized in Table 1.
Attention Network Test
Participants performed the attention network test described in
the original paper by Fan and colleagues (12). Subjects were
seated at a viewing distance of 65 cm in front of a 19-inch
computer screen, with a refresh rate of 75Hz. The task was
to respond as quickly as possible to a target arrow, presented
slightly above or below the fixation point, pointing left or right,
by pressing the corresponding keyboard key (Figure 1). The
target arrow was surrounded by four flankers which were either
congruent or incongruent arrows or neutral lines. The target
was preceded by one of four cue conditions: no cue, center,
double or spatial cue. Subjects were informed that the center,
double and spatial cues were temporally informative, as they
always preceded the arrow by 400ms. The spatial cue additionally
indicated the location of the arrow with 100% accuracy. Subjects
were instructed to try to maintain fixation on the fixation cross at
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TABLE 1 | Study participant characteristics.
Healthy control
(n = 30)
Organic movement disorder
(n = 30)
Functional movement disorder
(n = 30)
M:F 14:16 15:15 13:17
Age (range) 44.7 y (24–79 y) 48.0 y (21–77 y) 47.5 y (21–79 y)
Movement disorder None: 30 Action tremor
• upper limb: 22
• head: 8
• voice:5
Weakness: 1
Dystonia
• cervical: 13
• segmental: 2 2
• hands/writer’s cramp: 5
• oromandibular:1
• laryngeal: 4
Myoclonus: 1
Functional action tremor
• upper limb: 24
• lower limb: 6
• head: 2
• palate: 1
Functional weakness: 6
Functional dystonia: 6
Functional gait disorder: 5
Paroxysmal FMD: 4
Functional myoclonus: 1
Functional stiffness: 2
Medication (daily medication that
may affect attention)
Antidepressants
• SSRI: 2
• SSNRI: 1
Benzodiazepines: 3
Anticholinergics: 1
Antidepressants
• SSRI: 3
• SSNRI: 1
Antiepileptics
• pregabalin: 1
Benzodiazepines: 5
Antidepressants
• SSRI: 6
• SSNRI: 2
• Tricyclic: 2
• Tetracyclic: 1
Antiepileptics
• pregabalin/gapapentin: 8
• carbamazepine: 1
Opioids
• non-morphine: 5
• morphine-like: 3
Neuroleptics: 2
Anxiety HADS—A sub-score (SD) 5.2 (3.5) 7.0 (3.6) 8.9 (4.6)
Depression HADS—D sub-score
(SD)
2.4 (2.5) 3.7 (2.4) 8.0 (3.8)
The organic action tremors were caused by dystonic tremor, essential tremor and Wilson’s disease in one case. Note that 15 FMD patients and 27 organic controls had more than one
movement disorder type and 11 FMD and 3 organic controls took more than one analgesic. “Functional gait disorder” comprised a functional gait disorder not explained by any other
listed FMD type. SSRI, selective serotonin reuptake inhibitor; SSNRI, selective serotonin and noradrenaline reuptake inhibitor. HADS, Hospital Anxiety and Depression Scale (score ≤7:
normal, 8–10: mild, 11–14: moderate, 15-−21 severe affection).
all times. Each cue condition was presented on¼ and each flanker
on 1/3 of the trials.
After 24 practice trials with feedback as to the correctness
and the response speed, 288 trials were performed in three
blocks. Stimuli were presented and the responses recorded
using Matlab R© R2015b (Mathworks, Natick, MA, USA) in
conjunction with the Cogent 2000 toolbox (www.vislab.ucl.
ac.uk/cogent.php). STATA R© (StataCorp. 2013. Stata Statistical
Software: Release 13. TX: StataCorp LP) was additionally used
for data analysis.
Analysis
Trials for which the reaction time was too slow (>1,700ms),
even after having been repeated once and incorrect trials were
excluded from all analyses. Similar to previous literature, reaction
times that fell more than 1.5 times the interquartile range above
the 3rd or below the 1st quartile within each subject were
excluded as outliers (HC: 2.8% of trials, OC: 2.4%, FMD 3.6%)
(16, 17).
If the assumptions of the parametric tests were not met, the
equivalent non-parametric test was performed. Since ANOVA
is relatively robust to departures from normality (18) and the
sample sizes were always equal, it was performed as long as
the variances were not unequal. Multiple comparisons were
corrected by the Šidák-Holm method; the uncorrected test
statistic and effect size are shown, together with the corrected
p-value. The significance level was set at 0.05, two-tailed.
RESULTS
Age and Gender
The age between the three groups was not significantly
different (one-way ANOVA [F(2, 87) = 0.41, p = 0.67],
nor was the male to female ratio (Pearson’s chi-square
χ
2(2)= 0.27, p= 0.87).
Error Rates
In terms of error rates there was no significant difference
between the three groups for either flanker type (Kruskal–Wallis:
congruent flankers (HC:M = 0.61%, SD= 1.08, OC:M = 0.28%,
SD = 0.48, FMD: M = 0.36%, SD = 0.58): χ2(2) with ties =
0.99, p = 0.61, η2 = 0.012, neutral flankers (HC: M = 0.96%,
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FIGURE 1 | Attention network test experimental setup.
SD= 1.30, OC: M= 0.71%, SD= 0.81, FMD:M = 0.67%, SD=
1.47): χ2(2) with ties = 1.97, p = 0.37, η2 = 0.0004, incongruent
flankers (HC: M = 4.1%, SD = 3.6, OC: M = 3.2%, SD = 2.7,
FMD:M= 3.8%, SD= 4.0):χ2(2) with ties= 0.81, p= 0.67, η2 =
0.014. Significantly more errors (pressed the wrong key) occurred
with incongruent flankers (M = 3.71%, SD = 3.45) than with
either congruent (M = 0.42, SD = 0.76) or neutral flankers (M
= 0.78, SD = 1.22) [Kruskal–Wallis χ2(2) with ties = 107.7, η2
=0.40, p = 0.0001, Holm-Šidák corrected two-sample Wilcoxon
rank-sum tests incongruent vs. congruent: zuncorr = −9.26, pcorr
< 0.001, incongruent vs. neutral zuncorr =−8.11, pcorr < 0.001].
Overall RT
FMD patients had significantly slower overall reaction times than
either control group (Table 2) (one-way ANOVA [F(2,87) = 8.74,
p = 0.0003, η2 = 0.17]; post-hoc two-sample t-tests with Šidák-
Holm correction: FMD vs. HC tuncorr(58)=−3.81, pcorr = 0.001,
d = −0.98, FMD vs. OC tuncorr(58) = −2.69, pcorr = 0.019, d =
−0.69, HC vs. OC tuncorr(58)=−1.39, pcorr = 0.17, d =−0.36).
The fact that patients with FMD had overall slower reaction
times canceled itself out in the alerting, orienting and conflict
effects, since these effects were calculated by subtracting the
reaction time with one type of cue or flanker from another.
Alerting, Orienting, and Conflict Effects
As in the original paper, the alerting, orienting and conflict effects
were calculated in the following manner for each subject:
Alerting effect = RT No cue – RT double cue
Orienting effect = RT center cue – RT spatial cue
Conflict effect = RT incongruent flanker – RT congruent flanker
Note that for the alerting effect the double cue was used as
it is postulated that in both the “no cue” and the “double
cue” conditions the attentional focus is large. Hence the only
difference is the timing information. For the orienting effect, on
the other hand, the control was the single central cue as it leads
to attention to one location, similar to the spatial cue.
Since the question of interest is whether there is a difference
between the three groups for each of the attentional networks,
a separate one-way ANOVA was performed for each of the
alerting, orienting and conflict effects. The group difference was
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not significant for the alerting (HC:M = 36.3, SD= 17.4, OC:M
= 38.1, SD= 24.5, FMD:M = 33.2, SD= 26.8) [F(2,87) = 0.34, p
= 0.71, η2 = 0.008], nor for the orienting effect (HC: M = 46.4,
SD = 28.0, OC: M = 56.0, SD = 28.3, FMD: M = 53.8, SD =
27.9) [F(2,87) = 0.96, p = 0.39, η
2 =0.022], but it was significant,
with a large effect size for the conflict effect [F(2,87) = 9.03, p
= 0.0003, η2 = 0.17] (Figure 2). Šidák-Holm corrected pairwise
comparisons confirmed that there was a significant difference in
the conflict effect between the FMD group (M = 127.3, SD =
38.9) and either control group (HC:M = 90.0, SD= 28.0, OC:M
= 103.1, SD = 35.8) [FMD vs. HC two-sample t-tests tuncorr(58)
= −4.27, pcorr < 0.0002, d = −1.1, FMD vs. OC Wilcoxon rank
sum test: zuncorr = −2.53, pcorr = 0.023, r = −0.33], but not
between the two control groups (Wilcoxon rank sum test: zuncorr
=−1.21, pcorr = 0.23, r =−0.16).
The effects in the healthy controls were similar to those in
the original paper by Fan et al., in which the alerting effect was
47ms (SD= 18ms), the orienting effect 51ms (SD= 21) and the
conflict effect 84ms (SD= 25ms) (12).
FMD patients had significantly higher anxiety scores on the
HADS (Hospital Anxiety and Depression score) than healthy
controls, but not than their organic counterparts (one-way
ANOVA: [F(2,87) = 6.87, p = 0.0017, η
2 = 0.14]; post-hoc Šidák
corrected two-sample t-tests FMD vs. HC tuncorr(58) = −3.57,
pcorr = 0.001, FMD vs. OC: tuncorr(58) = −1.82, pcorr = 0.17,
HC vs. OC tuncorr(58) = −1.98, pcorr = 0.21). The depression
scores were higher in the FMD group than in the OC group,
with the latter having higher scores than the healthy controls
(one-way ANOVA: [F(2,87) = 29.7, η
2 = 0.41, p < 0.0001]; Šidák-
Holm corrected two-sample Wilcoxon rank sum tests: FMD vs.
HC zuncorr = −5.12, p < 0.001, FMD vs. OC zuncorr = −4.41,
pcorr < 0.001, HC vs. OC zuncorr = −2.36, pcorr = 0.018).
The higher antidepressant use in the respective groups reflected
these differences.
TABLE 2 | Reaction times for the different cues, flanker types, and overall for the three groups.
Cue
RT in ms (SD)
Flanker
RT in ms (SD)
Overall
RT in ms (SD)
None Center Double Spatial Congruent Neutral Incongruent
HC (n = 30) 638.9 (94.6) 612.3 (99.0) 602.6 (92.4) 566.0 (97.5) 576.4 (90.7) 575.9 (92.0) 666.3 (106.0) 604.7 (95.0)
OC (n = 30) 674.9 (99.8) 651.2 (99.8) 636.8 (97.7) 595.2 (96.3) 606.8 (94.5) 605.2 (92.2) 709.8 (109.4) 639.3 (97.4)
FMD (n = 30) 754.6 (152.0) 738.7 (144.7) 721.4 (137.8) 684.9 (145.2) 685.0 (139.7) 683.3 (136.4) 812.3 (158.0) 724.7 (144.0)
The group average reaction times are given in milliseconds, the standard deviations are in brackets. Note that for the cue types the different flanker types are collapsed together and
vice versa.
FIGURE 2 | Alerting, orienting and conflict effect group averages. Statistically significant Šidák-Holm corrected results are marked by asterisks: * pcorr < 0.05, ** pcorr
< 0.001. The standard error of the mean is shown by the error bars.
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So as to exclude that the observed difference between the
groups was caused by medications or additional medical
conditions that might have affected attention, the analysis
was repeated after all subjects on relevant daily medication
(benzodiazepines, opioids, antiepileptics, antidepressants,
neuroleptics, anticholinergics) were excluded. This also excluded
subjects with chronic pain, depression or anxiety important
enough to warrant medication. Analysis of the remaining
27 healthy controls, 23 organic controls and 14 functional
movement disorders patients gave the same conclusion for the
alerting, orienting and conflict effect. (Kruskal–Wallis test was
not significant for the alerting effect (χ2(2) = 0.70, p = 0.70, η2
= 0.021), nor for the orienting effect (χ2(2) = 2.49, p = 0.29,
η
2 = 0.0080), but it was significant with a moderate to large
effect size for the conflict effect (χ2(2) = 8.83, p = 0.012, η2
= 0.11). Šidák-Holm corrected, two-sample t-test confirmed
that there was a significant difference between the FMD group
(M = 127.1ms, SD = 40.0) and the healthy controls (M =
89.1ms, SD = 29.4) [tuncorr(39) = −3.47, pcorr = 0.0026, d =
−1.14]. Similarly, Šidák-Holm corrected two-sample Wilcoxon
rank-sum test gave a significant difference between the FMD
group and the organic controls (M = 98.5ms, SD= 32.0) (zuncorr
= −2.25, pcorr = 0.024, r = –0.37). The overall RT in all subjects
not on any relevant medication showed a trend to a difference
between the three groups (Kruskal–Wallis test: χ2(2) = 5.73, p
= 0.057, η2 = 0.061), with Šidák-Holm corrected, two-sample
t-tests showing a significant difference between the FMD group
(M = 731.6ms, SD = 175.2) and the healthy controls (M =
604.4ms, SD = 97.8) [tuncorr(39) = −3.00, pcorr = 0.0094, d =
−0.99] and between the FMD group and the organic controls (M
= 629.2ms, SD = 97.9), [tuncorr(35) = −2.29, pcorr = 0.028, d
=−0.78].
Within each group, the reaction times with congruent and
neutral flankers were virtually identical (Table 2). Thus, the
group difference for the conflict effect was due to incongruent
flankers leading to stronger inhibition in people with FMD rather
than congruent flankers providing stronger facilitation.
Side
Note that responses on the more affected side (which could
include an ipsilateral body part other than the arm) in subjects
with asymmetric symptoms (15 FMD patients, 25 OC patients),
were not significantly slower in either group compared to the
responses with the less affected side [one-sample t-test of the
difference between the more and less affected side in FMD: t(14)
= 0.51, p= 0.62, in OC t(24) = 0.96, p= 0.35].
DISCUSSION
We found a specific isolated abnormality in executive function in
FMD, based on a standard test of attention, the ANT. This test
measures three distinct components of visual attention, namely
alerting (being prepared for an event occurring), orienting
(shifting spatial processing resources to a specific location) and
conflict processing (overcoming a response tendency triggered
by distracting information). We found preserved orienting and
alerting functions of the attentional system in a group of FMD
patients. However, we observed an executive dysfunction related
to conflict resolution in our FMD group, notably a failure to
inhibit the effects of incongruent distractor information.
A possible limitation is that our movement disorder groups
comprised a large number of people with upper limb tremor
which might have directly interfered in their responses. The
study could be repeated with even more varied groups or by
using verbal responses (voice switch) rather than key presses.
Nevertheless, it is very unlikely that the upper limb tremor in
the FMD group could explain the current findings, since the
movement disorder control group had a very similar number of
upper limb tremors; the reaction times between the more and
less symptomatic sides in people with asymmetric symptoms did
not differ significantly in either group; and the three component
effects of the ANT are computed as differences between reaction
times. Thus, overall slower RTs in the FMD group would not
affect the results. It is also evident that the observed executive
dysfunction in FMD cannot be attributed to the simple presence
of a movement disorder, or a disease in general, since we did not
observe an equivalent effect in the organic movement disorders
group. It is furthermore independent of medication use, pain and
psychiatric comorbidities. The present study also suggested that
the overall increased reaction times in the functional movement
disorders group [see also (19, 20) for similar results] were
largely independent of medication use, pain and psychiatric
comorbidities. Fatigue, which is common in FMD, or poor task
performance could have had an effect on attention, but this would
have been expected to additionally affect the alerting component,
and not selectively the executive system.
Is this executive dysfunction a pre-existing and possibly
predisposing trait of FMD or is it a secondary effect? A limitation
of this study is that it cannot answer this question directly. The
ANT would have to be performed in a cohort of recovered
patients, or ideally in the same individuals while symptomatic
and after recovery. Nevertheless, clinical information and
functional imaging data point to it being a secondary effect.
Patients do not tend to report pre-existing executive difficulties
such as the inability to multitask, concentration difficulties, or
even fatigue. Similarly, these symptoms tend to improve during
recovery. In the functional imaging literature the executive
task of the ANT is reported to activate the anterior cingulate
cortex and the prefrontal cortex, particularly the medial frontal
cortex (11, 21). The same regions, the ventromedial prefrontal
cortex (22–24) and anterior cingulate cortex (25) have previously
been reported to show increased activity in patients with
functional movement disorders. Importantly, a recent case report
demonstrated abnormal medial prefrontal cortex activation in a
patient with functional paresis, which normalized after recovery
(24). Prefrontal cortical activation has often been interpreted
as being due to inhibition of the motor system or of limbic
induced abnormal motor patterns (24, 25). Yet an alternative
explanation is that it is due to increased self-monitoring and
hence increased utilization of the executive function of attention
during movement (23). In line with this hypothesis, a PET
study in healthy controls showed increased prefrontal cortical
activation when a complex finger tapping sequence was learned,
disappearance of this activation once the sequence was well
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practiced and hence performed automatically, and reappearance
of this prefrontal cortical activation when participants were asked
to attend to what they were doing (26).
The vast majority of movements we make throughout the day
are done implicitly, automatically. Yet in functional movement
disorders this implicit, low-level control of movement seems
to be overridden by explicit, high-level control. As a result,
movement becomes unusually cognitively demanding, and
draws heavily on limited cognitive resources. Cognitive motor
interference with worsening motor function with concomitant
cognitive tasks and vice versa is well-established (27, 28). We
therefore suggest that the observed executive dysfunction in
FMD is secondary to overutilization of the executive network
for explicit movement control. In the context of limited
attentional resources, executive dysfunction is the likely flip
side of distractibility. Because attention is heavily involved
in functional movement disorders, its distraction away from
the movement leads to symptom improvement. Yet functional
movement disorders draw upon limited attentional resources.
Tasks that are less attentionally demanding, such as alerting and
orienting in space are performed normally. Yet, the remaining
attentional resources are insufficient to perform attention heavy
executive tasks. Most participants with FMD had an upper limb
tremor, and many commented on the presence of their arm
unrelated movement disorder during the task. Thus, even though
participants were only pressing two keys in a seated position,
the functional movement disorders seemed to draw on their
attentional resources during the task, thereby preventing them
from directing their full attention to it.
Importantly, these findings of impaired executive function
provide a so far elusive explanation for many associated,
but hitherto seemingly unrelated symptoms. Overutilization of
the limited attentional resources by the functional movement
disorder, with resulting executive dysfunction for other tasks, can
explain why patients with FMD typically complain of cognitive
difficulties that are mostly attentional in nature: inability
to multitask, concentration difficulties, and the increasingly
commonly used term “brain fog,” which is suggestive of
inattention. Furthermore, it provides an explanation for the
somehow inappropriately termed “huffing and puffing sign” in
which relatively simple tasks or movements are performed with
extreme slowness and high apparent effort. Finally, fatigue can be
explained by a high utilization of attentional resources for even
the simplest of movements with an additional subsequent lack of
executive resources for other tasks, making both movements and
mental activity cognitively harder. A further study could directly
study the correlation between the cognitive complaints and/or
fatigue with the degree of executive dysfunction in the ANT.
Whether in addition to its impact on cognitive function
and fatigue, executive dysfunction negatively impacts functional
movement disorders directly, thereby forming a vicious circle,
remains an open question. Inability to switch between tasks
and shift attention away from the abnormal movements would
certainly have a negative impact, since one of the keys to
improving functional movement disorders is to be able to shift
attention away from the abnormal movements. Thus, executive
dysfunction in FMDmight merit treatment in its own right.
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